Development of a chart that can be used to aid prediction of hidden cancerous growths in colorectal cancer patients before surgery

ISRCTN ISRCTN76852032
DOI https://doi.org/10.1186/ISRCTN76852032
Submission date
08/03/2022
Registration date
16/03/2022
Last edited
01/02/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Bowel cancer is a general term for cancer that begins in the large bowel. Depending on where the cancer starts, bowel cancer is sometimes called colon or rectal cancer.
Early diagnosis of cancer spreading to the lining of the abdomen (peritoneal metastasis (PM)) is crucial to optimal treatment selection and improvement of survival, but it remains a challenge due to the high rate of missed diagnosis on computed tomography (CT) images. The aim of this study was to develop a chart for the identification of PM status in colorectal cancer (CRC) patients.

Who can participate?
Patients undergoing surgery for colorectal cancer.

What does the study involve?
Patient records of enhanced CT and laparoscopic exploration from 30/08/2007 to 26/09/2019 were analysed.

What are the possible benefits and risks of participating?
None

Where is the study run from?
The Sixth Affiliated Hospital, Sun Yat-sen University (China)

When is the study starting and how long is it expected to run for?
June 2020 to June 2021

Who is funding the study?
This study was sponsored by the National Natural Science Foundation of China (grant No. 82103084) and the Sun Yat-sen University Clinical Research 5010 Program (grant No. 2019021).

Who is the main contact?
Hui Wang, wang89@mail.sysu.edu.cn
Huaiming Wang, wanghm7@mail.sysu.edu.cn

Contact information

Dr Yuanxin Zhang
Principal Investigator

No.26 Yuancun Road
Tianhe District
Guangzhou
510655
China

ORCiD logoORCID ID 0000-0002-9761-7933
Phone +86 17665066505
Email zhangyx295@mail2.sysu.edu.cn

Study information

Study designObservational longitudinal case-control study
Primary study designObservational
Secondary study designCase-control study
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not applicable (retrospective study)
Scientific titlePredicting preoperative occult peritoneal metastasis in colorectal cancer patients: Development and external validation of a nomogram and study of its utility
Study acronymOPM
Study objectivesEarly diagnosis of peritoneal metastasis (PM) is crucial to optimal treatment selection and improvement of prognosis, but it remains a challenge due to the high rate of missed diagnosis on computed tomography (CT) images. The aim of this study was to develop a nomogram for identification of preoperative occult PM status in colorectal cancer (CRC) patients, which can serve as a potential decision-making support tool and guide individualized care.
Ethics approval(s)Approved 17/06/2020, China Research Ethics Committee (Yuancun street, Guangzhou, Guangdong 510515, China; lunli66@126.com; +44 20-38379764), ref: 2020ZSLYEC–109
Health condition(s) or problem(s) studiedPredicting preoperative occult peritoneal metastasis in colorectal cancer patients
InterventionAll enrolled patients were initially diagnosed as PM-negative by CT readings, but later confirmed with the actual PM status during the laparoscopic exploration. The patients were divided into two cohorts: one training cohort (n = 552 from center 1) and one external validation cohort (n = 70 from center 2).
All enrolled patients underwent enhanced CT examinations within two weeks before operation. The total duration of observation was from the diagnosis to the postoperative histological confirmation. The total duration of follow-up was not applicable because this study aimed to develop a risk model rather than a prognostic model.
Intervention typeOther
Primary outcome measureThe actual PM status confirmed using the intraoperative or postoperative histological evaluations at a single time point
Secondary outcome measuresThe predictive accuracy measured using receiver operating characteristic curve and calibration curves at a single time point
Overall study start date17/06/2020
Completion date17/06/2021

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants500
Total final enrolment662
Key inclusion criteriaCurrent inclusion criteria as of 28/03/2022:
1. Patients were diagnosed with CRC by endoscopy-biopsy pathology, combined with CT and/or other examinations
2. Patients had only one malignant primary tumor
3. Patients did not undergo previous resection of the primary tumor
4. Patients underwent both enhanced CT and laparoscopic exploration

Previous inclusion criteria:
1. Diagnosed CRC by endoscopy-biopsy pathology, combined with CT and/or other examination
2. With no other malignant primary tumours
3. With no previous abdominal malignancies or inflammatory diseases
4. With no previous resection of primary tumour
5. With both enhanced CT and laparoscopic exploration.
Key exclusion criteriaCurrent exclusion criteria as of 28/03/2022:
1. Typical PM signs on CT
2. Other distant metastases
3. Previous inflammatory diseases

Previous exclusion criteria:
1. With typical PM signs on CT
2. With other distant metastases
3. Incomplete or missing information
Date of first enrolment30/08/2007
Date of final enrolment26/09/2019

Locations

Countries of recruitment

  • China

Study participating centres

The Sixth Affiliated Hospital, Sun Yat-sen University
No.26 Yuancun Road
Tianhe Distrcit
Guangzhou
510655
China
Zhujiang Hospital, Southern Medical University
No.253 Gongye Road
Haizhu Distrcit
Guangzhou
510000
China

Sponsor information

The Sixth Affiliated Hospital of Sun Yat-sen University
Hospital/treatment centre

No.26 Yuancun Road
Tianhe District
Guangzhou
510655
China

Phone +86 20-38254000
Email 735212425@qq.com
Website https://www.zs6y.com

Funders

Funder type

Government

National Natural Science Foundation of China
Government organisation / National government
Alternative name(s)
Chinese National Science Foundation, Natural Science Foundation of China, National Science Foundation of China, NNSF of China, NSF of China, 国家自然科学基金委员会, National Nature Science Foundation of China, Guójiā Zìrán Kēxué Jījīn Wěiyuánhuì, NSFC, NNSF, NNSFC
Location
China
Sun Yat-sen University Clinical Research 5010 Program

No information available

Results and Publications

Intention to publish date01/01/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
zhangyx295@mail2.sysu.edu.cn

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 13/07/2022 02/08/2022 Yes No

Editorial Notes

01/02/2023: Internal review.
02/08/2022: Publication reference added.
28/03/2022: The inclusion and exclusion criteria were updated.
10/03/2022: Trial's existence confirmed by China Research Ethics Committee